Stewart Harris
Chief Financial Officer
Joined in 2009
Born in 1969
British national
Appointed in 2024
Stewart Harris began his career with KPMG in the UK before joining Roche in 1995, as the Financial Accountant of their local Vitamins manufacturing site. In 1998 he moved to Switzerland where he worked as a regional controller in Corporate Finance, before becoming the Finance Manager for Roche Vitamins in Australia and afterwards the Regional Finance Director in China. From 2003, Stewart was the regional finance head for DSM in China and prior to joining Givaudan held a global project role at DSM Nutritional Products, based in Switzerland.
Stewart joined Givaudan in 2009 where he has held successive roles of increasing responsibility, including as the Head of Group Treasury, Tax and Insurance and more recently as the Head of Corporate Finance and Business Development, based in Vernier, Switzerland. In these roles he was responsible for financial reporting, compliance and risk management, planning and management of Givaudan’s business development activities, as well as the Company’s five-year strategy development process. Over the past 8 years, Stewart has been responsible for leading the Company’s M&A activities. He was instrumental to the completion of many of Givaudan’s successful acquisitions, contributing to fuelling growth and transformation.
He is appointed Chief Financial Officer effective 1 August 2024.
Other mandates held by Stewart Harris are: Chairman of Loonawell AG, a Zurich-based start-up in the Ultra Premium Pet Nutrition market.
Stewart graduated from a KPMG accountancy traineeship in Glasgow, UK and subsequently qualified as a fellow of the Chartered Association of Certified Accountants.